Cantitate/Preț
Produs

Cancer Vaccines as Immunotherapy of Cancer

Editat de Luigi Buonaguro, Sjoerd Van Der Burg
en Limba Engleză Paperback – 23 mar 2022
Cancer Vaccines as Immunotherapy of Cancer provides extensive and state-of-the-art information about the meaning, relevance and limitation of therapeutic cancer vaccines. It covers all the aspects involved in the vaccine research and development (identification of optimal target antigens, formulations, delivery strategies, adjuvants among others) as well as their use in combination with other immunomodulatory approaches.
The book discusses topics such as identification of tumor associated and specific antigens, proteogenomic for identification of novel target tumor antigens, antigen-specific T cells, and Peptide and RNA based vaccines. Additionally, it covers oncolytic viruses for antigen delivery, cancer vaccine targeting viral antigens and combinatorial immunotherapy strategies.
Written by leading experts worldwide, this is a valuable resource for cancer researchers, oncologists and members of biomedical field who wants to understand in depth the recent findings in the field of cancer vaccines.


  • Describes the state-of-the-art of the research and development of therapeutic cancer vaccines
  • Presents detailed diagrams to help the reader understand the functionality of each type of vaccine discussed
  • Encompasses recent findings in the field through chapters written by leading experts worldwide
Citește tot Restrânge

Preț: 68440 lei

Preț vechi: 89894 lei
-24% Nou

Puncte Express: 1027

Preț estimativ în valută:
13102 13619$ 10863£

Carte tipărită la comandă

Livrare economică 30 ianuarie-13 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780128239018
ISBN-10: 0128239018
Pagini: 272
Ilustrații: 30 illustrations (15 in full color)
Dimensiuni: 152 x 229 x 19 mm
Greutate: 0.37 kg
Editura: ELSEVIER SCIENCE

Cuprins

1. Introduction2. Identification of Tumor Associated Antigens3. Identification of Tumor Specific Antigens4. Proteogenomics for identification of novel target tumor antigens5. Antigen-specific T cells6. Tumor antigens for preventive strategies7. Peptide based vaccines8. RNA based vaccines9. Novel dendritic cells strategies10. Oncolytic viruses for antigen delivery11. Cancer vaccine targeting viral antigens12. Combinatorial immunotherapy strategies13. Conclusions